High levels of depression found among Canadian older adults with cancer during the COVID-19 pandemic

by University of TorontoCredit: Unsplash/CC0 Public DomainOlder adults who have had cancer had a high risk of experiencing symptoms of depression during the early months of the COVID-19 pandemic

Updated on: February 18,2024

High levels of depression found among Canadian older adults with cancer during the COVID-19 pandemic

by University of TorontoCredit: Unsplash/CC0 Public DomainOlder adults who have had cancer had a high risk of experiencing symptoms of depression during the early months of the COVID-19 pandemic

Updated on:February 18,2024

Study identifies new treatment target for metastatic cancer

by Elizabeth Chapin,University of KentuckySuccinate levels are elevated during EMT. (A) Expression of EMT markers was assessed by western blot in control, Snail1- and Twist1-expressing HMLE cell

Updated on: February 18,2024

Study identifies new treatment target for metastatic cancer

by Elizabeth Chapin,University of KentuckySuccinate levels are elevated during EMT. (A) Expression of EMT markers was assessed by western blot in control, Snail1- and Twist1-expressing HMLE cell

Updated on:February 18,2024

Researchers find superantigen mutant can trigger immune response in ovarian cancer cells

by Liu Jia,Chinese Academy of SciencesThe transwell co-culture models of transcriptome experiment. Credit:International Journal of Molecular Sciences(2023). DOI: 10.3390/ijms24141179

Updated on: January 30,2024

Researchers find superantigen mutant can trigger immune response in ovarian cancer cells

by Liu Jia,Chinese Academy of SciencesThe transwell co-culture models of transcriptome experiment. Credit:International Journal of Molecular Sciences(2023). DOI: 10.3390/ijms24141179

Updated on:January 30,2024

Experimental monoclonal antibodies can coax aggressive prostate and breast cancers into submission, finds research

by Delthia Ricks , Medical XpressTherapeutic inhibition of VEGF binding to NRP2 activates anti-tumor immunity in a syngeneic model of prostate cancer that is resistant to aPD-L1 therapy. (A) Shown is

Updated on: January 23,2024

Experimental monoclonal antibodies can coax aggressive prostate and breast cancers into submission, finds research

by Delthia Ricks , Medical XpressTherapeutic inhibition of VEGF binding to NRP2 activates anti-tumor immunity in a syngeneic model of prostate cancer that is resistant to aPD-L1 therapy. (A) Shown is

Updated on:January 23,2024

Review covers progress in immunotherapy for esophageal cancer

by Cactus CommunicationsMultiple ongoing clinical trials are being conducted to test the potential of ICIs as an adjuvant therapy for resectable esophageal cancer. The results of these trials could ce

Updated on: January 22,2024

Review covers progress in immunotherapy for esophageal cancer

by Cactus CommunicationsMultiple ongoing clinical trials are being conducted to test the potential of ICIs as an adjuvant therapy for resectable esophageal cancer. The results of these trials could ce

Updated on:January 22,2024

Arthritis linked to blood cancer mutations

by South Australian Health and Medical Research Institute (SAHMRI)Credit: Pixabay/CC0 Public DomainA team of Adelaide and U.S. researchers has discovered a link between a less common form of rheumatoi

Updated on: April 28,2024

Arthritis linked to blood cancer mutations

by South Australian Health and Medical Research Institute (SAHMRI)Credit: Pixabay/CC0 Public DomainA team of Adelaide and U.S. researchers has discovered a link between a less common form of rheumatoi

Updated on:April 28,2024

Researchers identify novel gene networks associated with aggressive type of breast cancer

by Savannah Williamson,Georgia Institute of TechnologyGene enrichment for select Basal-like network modules. Network diagram for eight nonconserved Basal-like modules that include OS genes. Node

Updated on: April 28,2024

Researchers identify novel gene networks associated with aggressive type of breast cancer

by Savannah Williamson,Georgia Institute of TechnologyGene enrichment for select Basal-like network modules. Network diagram for eight nonconserved Basal-like modules that include OS genes. Node

Updated on:April 28,2024

Patients coping with mesothelioma experienced higher levels of toxicity on CheckMate743 regimen than reported in trials

by International Association for the Study of Lung CancerCredit: Pixabay/CC0 Public DomainBased on results from the CheckMate743 trial, the dual regimen of ipilimumab and nivolumab is the standard of

Updated on: April 10,2024

Patients coping with mesothelioma experienced higher levels of toxicity on CheckMate743 regimen than reported in trials

by International Association for the Study of Lung CancerCredit: Pixabay/CC0 Public DomainBased on results from the CheckMate743 trial, the dual regimen of ipilimumab and nivolumab is the standard of

Updated on:April 10,2024

Doctors and nurses reluctant to recommend e-cigarettes to cancer patients

by National Cancer Research InstituteCredit: CC0 Public DomainTwenty-nine per cent of health professionals would not recommend e-cigarettes to cancer patients who already smoke, according to research

Updated on: May 17,2024

Doctors and nurses reluctant to recommend e-cigarettes to cancer patients

by National Cancer Research InstituteCredit: CC0 Public DomainTwenty-nine per cent of health professionals would not recommend e-cigarettes to cancer patients who already smoke, according to research

Updated on:May 17,2024

3-D scaffold map to help the search for new cancer treatments

by Walter and Eliza Hall Institute of Medical ResearchScientists have solved the 3-D structure of molecular scaffold SgK223, which is known to play a critical role in the development and spread o

Updated on: March 14,2024

3-D scaffold map to help the search for new cancer treatments

by Walter and Eliza Hall Institute of Medical ResearchScientists have solved the 3-D structure of molecular scaffold SgK223, which is known to play a critical role in the development and spread o

Updated on:March 14,2024

New regulator in aggressive breast cancer cells discovered

by Leibniz Institute on AgingThe protein TRPS1 controls the activity of the YAP protein in breast cancer. If YAP activity is downregulated, the survival prognosis for patients is reduced. If TRPS1 is

Updated on: April 22,2024

New regulator in aggressive breast cancer cells discovered

by Leibniz Institute on AgingThe protein TRPS1 controls the activity of the YAP protein in breast cancer. If YAP activity is downregulated, the survival prognosis for patients is reduced. If TRPS1 is

Updated on:April 22,2024

Pancreatic cancer's addiction could be its end

by Cold Spring Harbor LaboratoryThe researchers looked for various indicators of tumor activity in normal pancreas cells (top row) comparing results to those from when the production of the P63 p

Updated on: May 13,2024

Pancreatic cancer's addiction could be its end

by Cold Spring Harbor LaboratoryThe researchers looked for various indicators of tumor activity in normal pancreas cells (top row) comparing results to those from when the production of the P63 p

Updated on:May 13,2024